Cargando…
Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
OBJECTIVE: Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CV...
Autores principales: | Anderson, Robert J., Bahn, Gideon D., Moritz, Thomas E., Kaufman, Derrick, Abraira, Carlos, Duckworth, William |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005453/ https://www.ncbi.nlm.nih.gov/pubmed/21059830 http://dx.doi.org/10.2337/dc10-1420 |
Ejemplares similares
-
Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial
por: Agrawal, Lily, et al.
Publicado: (2011) -
Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
por: Florez, H, et al.
Publicado: (2015) -
Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)
por: Saremi, Aramesh, et al.
Publicado: (2010) -
Association of PAI-1 and Fibrinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
por: Azad, Nasrin, et al.
Publicado: (2014) -
Basic Fibroblast Growth Factor Predicts Cardiovascular Disease Occurrence in Participants from the Veterans Affairs Diabetes Trial
por: Zimering, Mark B., et al.
Publicado: (2013)